Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CHML

Next Previous
X
Search
Drug Profile

CHML

Alternative Names: Cytotropic heterogeneous molecular lipids

Latest Information Update: 29 Apr 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Glory Pharmaceuticals
  • Developer Glory Pharmaceuticals; National Cancer Institute (USA)
  • Class Antineoplastics; Saturated fatty acids; Triterpenes; Unsaturated fatty acids; Vitamins
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase III Cancer
  • Phase II Liver cancer

Most Recent Events

  • 12 Apr 2021 CHML is still in phase II trials for Liver cancer in China (Glory Pharmaceutical pipeline, April 2021)
  • 11 Oct 2018 CHML is still in clinical trials for Cancer (Glory Pharmaceuticals website, October 2018)
  • 27 Aug 2015 Development in Cancer is ongoing in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top